Thursday

27th Jul 2017

Resignation at EU drugs agency highlights ethics issues

  • Conflict of interests have to be properly managed to maintain consumers' trust, say consumer groups (Photo: Bart)

A top scientist within the EU agency authorising new drugs resigned on Wednesday (4 April) after being fired from France's national regulator, itself embroiled in scandals over poisonous diabetes drugs and failing breast implants.

Eric Abadie, a French specialist in diabetes and heart-related diseases, had for the past five years been chaired a panel of experts giving scientific advice to the European Medicines Agency on authorising the sale of new drugs on the EU market.

Thank you for reading EUobserver!

Subscribe now and get 40% off for an annual subscription. Sale ends soon.

  1. €90 per year. Use discount code EUOBS40%
  2. or €15 per month
  3. Cancel anytime

EUobserver is an independent, not-for-profit news organization that publishes daily news reports, analysis, and investigations from Brussels and the EU member states. We are an indispensable news source for anyone who wants to know what is going on in the EU.

We are mainly funded by advertising and subscription revenues. As advertising revenues are falling fast, we depend on subscription revenues to support our journalism.

For group, corporate or student subscriptions, please contact us. See also our full Terms of Use.

If you already have an account click here to login.

"I am not aware of any criminal charges made against Dr Abadie," Martin Harvey, a spokesman for the London-based EU agency told this website, adding that his resignation was linked to the other job Abadie was holding as top scientific adviser of France's national medicines regulatory body.

The spokesman explained that "almost all" experts sitting on the EU panel have a similar role at national level. "This does not present a conflict of interests in that it is important that the European and national agencies work together closely," Harvey said.

The French agency meanwhile has come under intense scrutiny for not having withdrawn authorisation for "Mediator", a diabetes drug - Abadie's field of expertise according to his CV - that was already banned in other countries and that is blamed for having killed at least 500 patients in France. Since December, the agency is also being accused of having given a green light to faulty breast implants filled with poisonous industrial silicone made by the now bankrupt French producer PIP.

A spokeswoman for the French agency told this website that Abadie's resignation is due to the fact that his post was scrapped during a 're-organisation' of the agency decided in December - at the peak of the PIP breast implants scandal. She refused to comment on the link between the scandal and Abadie's scientific advice.

"He decided to resign because his position within the EU agency was paid for by the French government and because the director of the EU agency did not give a favourable answer to taking over his salary," she explained.

The EU medicines agency already has come under fire for having turned a blind eye to close links to the pharma industry, with its former director resigning at the end of 2010 to go and work as a consultant for the drug industry only a few days later.

Last month, MEPs in the budgetary control committee refused to sign off the agency's accounts for 2010 over conflict of interest issues.

"The Abadie case is yet another example of the need to have independent experts working only for the EU agency and not for national bodies or other organisations. Conflict of interests are not only an opportunity for the industry to bend rules according to their needs, but can also endanger public safety," Romanian MEP Monica Macovei who drafted the parliament's position on the issue told this website.

Consumer protection groups have also rallied behind her. "We try to encourage these agencies to make an effort and resolve conflicts of interest, which are bad for consumers," said Jonathan La Morte from Beuc, the European umbrella organisation for consumer protection groups.

In a position paper sent to the European Parliament last month, Beuc stressed that the "effective management of conflict of interests are crucial to maintain consumers’ trust in the independence and in the quality of the scientific opinions of EMA and ultimately in the safety of the medicines they use."

MEPs divided on whether to punish EU agencies

MEPs are getting ready to vote on whether to punish three EU agencies for using public money for questionable purposes and for tolerating conflicts of interest.

Investigation

Inside the Code of Conduct, the EU's most secretive group

The informal group of national officials that is in charge of checking EU countries' tax laws is now working on the first EU blacklist of tax havens, amid critiques over its lack of transparency and accountability.

Ombudsman asks for more details on Barroso case

Emily O'Reilly has asked the EU Commission to say what former commissioners should be allowed to do after they leave office and explain why it took no decision over its former president's controversial new job.

Investigation

Inside the Code of Conduct, the EU's most secretive group

The informal group of national officials that is in charge of checking EU countries' tax laws is now working on the first EU blacklist of tax havens, amid critiques over its lack of transparency and accountability.

Ombudsman asks for more details on Barroso case

Emily O'Reilly has asked the EU Commission to say what former commissioners should be allowed to do after they leave office and explain why it took no decision over its former president's controversial new job.

News in Brief

  1. Member states relocate 3,000 migrants in June
  2. Top EU jurist says Malta's finch-trapping against EU law
  3. EU judges rule to keep Hamas funds frozen
  4. EU court rejects passenger data deal with Canada
  5. US votes in favour of Nord Stream II sanctions
  6. Greece makes return to bond market
  7. Trump accuses the EU of protectionism
  8. EU parliament's Brexit group urges progress on talks

Stakeholders' Highlights

  1. EU2017EELocal Leaders Push for Local and Regional Targets to Address Climate Change
  2. European Healthy Lifestyle AllianceMore Women Than Men Have Died From Heart Disease in Past 30 Years
  3. European Jewish CongressJean-Marie Le Pen Faces Trial for Oven Comments About Jewish Singer
  4. ACCAAnnounces Belt & Road Research at Shanghai Conference
  5. ECPAFood waste in the field can double without crop protection. #WithOrWithout #pesticides
  6. EU2017EEEstonia Allocates €1 Million to Alleviate Migratory Pressure From Libya in Italy
  7. Dialogue PlatformFethullah Gulen's Message on the Anniversary of the Coup Attempt in Turkey
  8. Martens CentreWeeding out Fake News: An Approach to Social Media Regulation
  9. European Jewish CongressEJC Concerned by Normalisation of Antisemitic Tropes in Hungary
  10. Counter BalanceOut for Summer Episode 1: How the EIB Sweeps a Development Fiasco Under the Rug
  11. CESICESI to Participate in Sectoral Social Dialogue Committee on Postal Services
  12. ILGA-EuropeMalta Keeps on Rocking: Marriage Equality on Its Way

Latest News

  1. EU defends airline data-sharing after court ruling
  2. Stop blaming Trump for Poland’s democratic crisis
  3. EU and US scrap on Russia sanctions gets worse
  4. Czechs, Hungarians, and Poles have one month to start taking migrants
  5. EU Commission sets red lines for Poland on Article 7
  6. Court told to 'dismiss' case against EU migrant quotas
  7. Russia's EU pipeline at 'risk' after US vote
  8. EU Commission to act on Poland